Trials / Sponsors / Jason Robert Gotlib
Jason Robert Gotlib
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis | Phase 2 | 2015-03-01 |
| Completed | Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis | Phase 2 | 2013-09-01 |
| Terminated | Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia Anemia, Leukemia, Acute Myeloid Leukemia (AML) | Phase 1 | 2009-11-01 |
| Completed | Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) | Phase 2 | 2005-03-01 |